6. Human Genotoxic Metabolites: Identification and Risk Management

  1. Andrew Teasdale
  1. Krista Dobo1,
  2. Don Walker2 and
  3. Andrew Teasdale3

Published Online: 3 JAN 2011

DOI: 10.1002/9780470929377.ch6

Genotoxic Impurities

Genotoxic Impurities

How to Cite

Dobo, K., Walker, D. and Teasdale, A. (2011) Human Genotoxic Metabolites: Identification and Risk Management, in Genotoxic Impurities (ed A. Teasdale), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470929377.ch6

Editor Information

  1. AstraZeneca, Leicester, United Kingdom

Author Information

  1. 1

    Pfizer, Groton, CT, USA

  2. 2

    ex. Pfizer, Sandwich, Kent, United Kingdom

  3. 3

    AstraZeneca, Leicester, United Kingdom

Publication History

  1. Published Online: 3 JAN 2011
  2. Published Print: 14 FEB 2011

ISBN Information

Print ISBN: 9780470499191

Online ISBN: 9780470929377


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Chapter for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >